Can Cuba beat COVID with its homegrown vaccines?

@article{Mega2021CanCB,
  title={Can Cuba beat COVID with its homegrown vaccines?},
  author={Emiliano Rodr{\'i}guez Mega},
  journal={Nature},
  year={2021}
}

Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It

This review looks into the efficacy and safety of COVID-19 vaccination booster to guide clinical decisions on when and who to receive booster vaccination.

Cuba—U.S. scientific collaboration: Beyond the embargo

Cuba and the U.S. have the oldest Academies of Sciences outside Europe. Both countries have a long history of scientific collaboration that dates to the 1800s. Both scientific communities also share

Vaccinations, The Journey So Far and The Road Ahead

This is review of the different types of vaccination techniques that have developed over time and how these have been utilised to address the SARS-CoV-2 virus.

COVID-19 Vaccinations: A Comprehensive Review of Their Safety and Efficacy in Special Populations

This review aims to evaluate the existing evidence of COVID-19 vaccinations on special populations and to provide clues to guide vaccination decision making to balance the benefits and risks of vaccinations.

Cuba—U.S. scientific collaboration: Beyond the embargo

The results of the bibliometric analysis of Cuba-U.S. joint publications in the Web of Science, and Scopus databases between 1980 to 2020 indicate sustained growth of scientific collaboration between scientists of both nations over the past forty years.

References

SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studies

It is shown that macromolecular constructs with recombinant RBD conjugated to tetanus toxoid induce a potent immune response in laboratory animals, paving the way for other viral conjugate vaccines based on the use of small viral proteins involved in the infection process.